Literature DB >> 237938

An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH.

E F Plow, T S Edgington.   

Abstract

An alternative fibrinolytic system, active at physiological pH, is present in peripheral blood leukocytes. The fibrinolytic proteases localized predominantly in the leukocyte granules are capable of degrading both fibrinogen and fibrin, and plasmin activity does not contribute significantly to this proteolytic event. The specificity of the alternative fibrinolytic proteases for fibrinogen and the characteristics of the derivative cleavage fragments are clearly distinguishable from the classical plasmin system. The high molecular weight derivatives of fibrinogen, generated by the alternative system, under physiological conditions, are larger than the plasmin-generated X fragment, exhibit immunoelectrophoretic mobility comparable to native fibrinogen, and are not coagulable by thrombin. Analysis of the constituent polypeptide chains of the fragments reveals cleavage of the Aalpha, Bbeta, and gamma chains of fibrinogen. The lower molecular weight derivatives of fibrinogen, generated by the alternative system, are structurally distinct from previously described fibrinogen degradation products and exhibit potent anticoagulant activity. This anticoagulant activity can be attributed to interference with normal fibrin polymerization. The proteases of the alternative fibrinolytic systems are actively secreted by leukocytes when stimulated to undergo a nonlytic release reaction. These results provide direct evidence for a fibrinolytic system resident in leukocyte granules that is associated with the leukocyte release reaction and is capable of generating unique fibrinogen cleavage fragments.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 237938      PMCID: PMC436552          DOI: 10.1172/JCI108076

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  ULTRASTRUCTURAL STUDY OF FIBRIN DISSOLUTION VIA EMIGRATED POLYMORPHONUCLEAR NEUTROPHILS.

Authors:  J M RIDDLE; M I BARNHART
Journal:  Am J Pathol       Date:  1964-11       Impact factor: 4.307

2.  [LEUKOCYTIC FIBRINOLYSIS].

Authors:  O CAVIEZEL; M VOLLERY; A VANNOTTI
Journal:  Schweiz Med Wochenschr       Date:  1964-07-18

3.  LEUKOCYTES AND THROMBOSIS.

Authors:  R L HENRY
Journal:  Thromb Diath Haemorrh       Date:  1965-03-15

4.  FIBRINOLYTIC PROPERTIES OF PROTEASES DERIVED FROM HUMAN, DOG AND RABBIT LEUKOCYTES.

Authors:  H GANS
Journal:  Thromb Diath Haemorrh       Date:  1964-01-01

5.  Proteases of human leukocytes.

Authors:  L A MOUNTER; W ATIYEH
Journal:  Blood       Date:  1960-01       Impact factor: 22.113

6.  Generation of chemotactic activity for leukocytes by the action of thrombin on human fibrinogen.

Authors:  A B Kay; D S Pepper; M R Ewart
Journal:  Nat New Biol       Date:  1973-05-09

7.  Influence of pH, ionic strength, neutral ions, and thrombin on fibrin polymerization.

Authors:  Z S LATALLO; A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  Am J Physiol       Date:  1962-04

8.  The mononuclear-cell response to injury.

Authors:  R A PAZ; W G SPECTOR
Journal:  J Pathol Bacteriol       Date:  1962-07

9.  Optimum reaction conditions for human lactate dehydrogenase isoenzymes as they affect total lactate dehydrogenase activity.

Authors:  R J Gay; R B McComb; G N Bowers
Journal:  Clin Chem       Date:  1968-08       Impact factor: 8.327

10.  Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activity in granules of human polymorphonuclear leukocytes.

Authors:  A Janoff; J Scherer
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  27 in total

1.  Synthesis of a fibrinolytic activator and inhibitor by endothelial cells.

Authors:  D J Loskutoff; T E Edgington
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

2.  Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B.

Authors:  R M Senior; W F Skogen; G L Griffin; G D Wilner
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

3.  Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus.

Authors:  M Cronlund; J Hardin; J Burton; L Lee; E Haber; K J Bloch
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

Review 4.  Disseminated intravascular coagulation: a review.

Authors:  P J Hamilton; A L Stalker; A S Douglas
Journal:  J Clin Pathol       Date:  1978-07       Impact factor: 3.411

5.  Circulating human leucocyte elastase in patients with inflammatory bowel disease.

Authors:  E O Adeyemi; S Neumann; V S Chadwick; H J Hodgson; M B Pepys
Journal:  Gut       Date:  1985-12       Impact factor: 23.059

6.  The contribution of leukocyte proteases to fibrinolysis.

Authors:  E F Plow
Journal:  Blut       Date:  1986-07

7.  Fibrinogenolysis by a neutrophil membrane protease generates an A alpha 1-21 fragment.

Authors:  S L Kelly; S A Adams; S C Robson; R E Kirsch; E G Shephard
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

Review 8.  Relationships among the complement, kinin, coagulation, and fibrinolytic systems.

Authors:  J S Sundsmo; D S Fair
Journal:  Springer Semin Immunopathol       Date:  1983

9.  Nonspecific protease and elastase activities in rat leukocytes.

Authors:  J Varani; D Ward; K J Johnson
Journal:  Inflammation       Date:  1982-06       Impact factor: 4.092

10.  Pulmonary embolism in patients with acute leukemia and severe thrombocytopenia.

Authors:  S W Needleman; M N Stein; J C Hoak
Journal:  West J Med       Date:  1981-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.